Where to buy Semaglutide in the UK: the licensed route is a prescription, and no research seller has a verifiable COA

Semaglutide is Novo Nordisk's Ozempic and Wegovy, a prescription-only medicine in the UK, so the licensed route is a prescription from a pharmacy; research-vial sellers offer unlicensed copies. Of the 450 UK research-peptide sellers we audit, none publishes a verifiable own-name Janoshik certificate naming Semaglutide, so there is no research-vial source whose testing you can check. It is a licensed prescription medicine, not a research peptide, so it sits in a tighter legal category The Peptide Watch does not list vendors for and does not endorse buying outside a prescription.

Why this matters more, not less, for Semaglutide

Grey-market Semaglutide is among the most faked compounds sold to UK buyers, and a vial that is under-dosed, the wrong compound, or contaminated cannot be judged by sight, price or packaging. The only objective evidence is an independent certificate you can verify. Learn the two-minute check in how to verify a Janoshik COA.

Verified UK vendors with a confirmed Semaglutide Janoshik certificate

None confirmed yet for Semaglutide specifically: we have not yet opened an own-name Janoshik report covering it from any verified vendor. Any of the 38 verified vendors is where testing can be checked; see the full list.

Audit findings, not recommendations. Every entry is a report covering Semaglutide that we opened on Janoshik's own site and that names the seller itself as the client; the date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The table below is the same ledger in full, so the two always agree. Not exhaustive: a vendor whose Semaglutide report we have not yet read is not listed.

Questions people ask

Semaglutide in the UK at a glance

Counted from the vendor ledger at build time: a seller is included when its audit records Semaglutide in its certificates or its catalogue notes. Audit findings, not recommendations.

The other 16 sellers: what they publish instead

• No named lab, nothing to verify: 7
• Claims testing but names no lab: 2
• Shows a supplier's certificate, not its own: 2
• No lab named: 2
• Hides behind an 'accredited UK lab': 1
• Reseller showing the maker's certificate: 1

Each pattern is explained on the seller's own audit page, with what we saw and the date. The A-Z directory lists every seller.

The market for Semaglutide in the UK

Companies. 2 of the 16 can be matched to a Companies House record; the median company is 4 months old and 2 were incorporated within the last year. A seller with no traceable company is not necessarily dishonest, but there is nobody to hold to its certificate.

Reviews. 1 of the 16 have a Trustpilot profile with a score; the median is 4.9, 1 sit at 4.5 or above and 0 below 3.0. A review score says who collects reviews, not who tests, which is why it sits next to a certificate and never instead of one.

Changes among Semaglutide sellers

• 2026-10-04 UK Peptide Store (ukpeptidestore.uk) left the audit (closed, parked, or out of scope).
• 2026-09-29 GLP1Health (glp1health.co.uk) left the audit (closed, parked, or out of scope).
• 2026-09-29 AurumLabs (aurum-labs.co) added to the audit on the watch list.
• 2026-09-29 RS Bio Labs (rsbiolabs.com) added to the audit on the watch list.
• 2026-09-29 Future Amino (future-amino.com) added to the audit on the watch list.
• 2026-09-22 RetatrutideStore UK (retatrutidestore.co) left the audit (closed, parked, or out of scope).

From the site changelog, which also runs as a JSON feed.

What the research shows for Semaglutide, and what it does not

The largest evidence base of any compound on this site. PubMed indexes 5,463 papers, 337 clinical-trial reports and 91 phase 3 reports; ClinicalTrials.gov lists 752 registered trials. It is Novo Nordisk's Ozempic, Wegovy and Rybelsus.

Licensed in the UK, as a prescription medicine. Semaglutide holds MHRA marketing authorisations for type 2 diabetes and for weight management, extended in 2026 to an oral Wegovy tablet and to metabolic dysfunction-associated steatohepatitis (MASH). The lawful supply is a pharmacy dispensing Novo Nordisk's product against a prescription.

A research-chemical vial is a different product. Whatever a verifiable certificate says about the powder in a vial, it is not the licensed medicine, and selling it as one is unlawful. The certificate answers one question only: whether an independent laboratory found the tested sample to be what the label says.

Who owns Semaglutide, and where it stands

Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file; "clinical trial" is PubMed's own publication-type index. This is a description of the published record, not medical advice and not an argument for or against use.

The Peptide Watch's position on Semaglutide

Semaglutide is a regulated medicine. The Peptide Watch audits research-peptide sellers and does not rank or recommend anywhere to buy Semaglutide; this page exists so the verification standard is clear. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are trusting marketing on a regulated medicine sold outside its licensed supply chain. See how UK research-peptide testing stacks up in the market statistics.